Author Archives: Jan Paschal

Biotechs are back in play. Two IPOs – Hemab Therapeutics (COAG Proposed) and Seaport Therapeutics (SPTX Proposed)   – launched early Monday to price on Thursday night, April 30, and trade Friday, May 1. Those deals joined Avalyn Pharma (AVLN Proposed) – a pulmonary fibrosis-focused biotech IPO that launched last week. All told, these three biotech […]

X-Energy (XE) upsized its IPO at pricing to 44.25 million shares – up from 42.86 million in the prospectus – and priced the deal at $23.00 – $4.00 above the top of its $16.00-to-$19.00 range – to raise about $1.02 billion on Thursday night, April 23, 2026. Shares of X-Energy (XE) jumped $7.11 from their […]

The Elmet Group (ELMT) upsized its IPO to 8.6 million shares at pricing – up from 7.7 million in the prospectus – and priced the IPO at $14.00 – the top of its $12.00-to-$14.00 range – to raise $120.4 million on Wednesday night, April 22, 2026. Shares of The Elmet Group (ELMT) jumped $4.00 to open at […]

National Healthcare Properties (NHP) priced its IPO at $12.00 – $1.00 below the bottom of its $13.00-to-$16.00 range on Tuesday night, April 21, 2026 – and sold 38.5 million shares – the number in the prospectus – to raise $462 million. Shares of National Healthcare Properties (NHP) dipped 44 cents below their IPO price to […]

Yesway (YSWY) priced its IPO at $20.00 – the low end of its $20.00-to-$23.00 range – and slightly upsized the deal at pricing to 14.0 million shares – up from 13.95 million in the prospectus – to raise $280 million on Tuesday night, April 21, 2026. Yesway’s stock started trading at $22.00 – up $2.00 […]

This week, IPO bankers are serving up an array of deals with a little something for everyone. The retail and food sectors are represented by Yesway (YSWY Proposed), while the nuclear energy industry is represented by X-Energy (XE Proposed). All told, IPO bankers are planning to price up to eight deals this week to raise […]

Aevex Corp. (AVEX), a drone company, priced its IPO at $20.00 – just above the $19.50 mid-point of its range – and sold 16 million shares – the number in the prospectus – to raise $320 million on Thursday night, April 16, 2026. Aevex (AVEX) climbed on Friday, April 17, opening at $23.01 – up […]

Alamar Biosciences (ALMR) upsized its IPO at pricing – to 11.25 million shares – up from 9.38 million in the prospectus –  and priced its IPO at $17.00 – the high end of its range – to raise $191.25 million on Thursday night, April 16, 2026.  Alamar Biosciences’ stock shot up $5.00 to open at […]

Kailera Therapeutics (KLRA), a biotech targeting obesity, upsized its IPO at pricing to 39.06 million shares – up from 33.33 million in the prospectus – and priced the deal at $16.00 – the top of its $14.00-to-$16.00 range – to raise $624.96 million on Thursday night, April 16, 2026. Kailera Therapeutics’ stock is expected to […]

Arxis (ARXS) upsized its IPO at pricing – to 40.5 million shares – up from 37.74 million in the prospectus – and priced its IPO at $28.00 – the top of its range – to raise $1.13 billion on Wednesday night, April 15, 2026. Shares of Arxis (ARXS) shot up $10.00 in their NASDAQ debut […]